80+ Medical Device Manufacturing Statistics for 2025-2026

Medical device manufacturing industry snapshot

If you want the short version, this is one of the strongest specialized manufacturing sectors in the U.S. It combines precision machining, plastics, electronics, sterilization, packaging, software, documentation, and regulatory work in a single value chain. That mix creates higher wages, stronger export demand, and more technical complexity than the average plant sees.

1. The U.S. medical technology industry supports nearly 2 million jobs when direct, indirect, and induced effects are included. Source: AdvaMed job creation data.
2. Direct medtech employment accounts for nearly 519,000 U.S. jobs. Source: AdvaMed.
3. The sector generates $381 billion in annual U.S. economic output, including supplier and spillover effects. Source: AdvaMed.
4. Average total compensation per worker is about $84,000. Source: AdvaMed.
5. The U.S. has more than 6,500 medical technology firms. Source: AdvaMed.
6. More than 80% of medical technology firms have fewer than 50 employees. Source: AdvaMed.
7. Annual U.S. medtech exports total more than $44 billion. Source: AdvaMed.
8. The industry reports a trade surplus of about 14%. Source: AdvaMed.
9. AdvaMed’s 2025 public campaign says U.S. medtech manufacturing drives $250 billion in output and supports 3 million jobs, showing how broad the ecosystem estimate gets when additional activity is counted. Source: AdvaMed Medtech Saves.
10. From 2014 to 2019, medtech sales, shipments, and revenues grew 2.6%, while overall manufacturing sales, shipments, and revenues fell 2.7%. Source: AdvaMed.

Jobs, firms, and wage statistics

Most manufacturing niches talk about labor shortages. Medical device manufacturing has the same issue, but it shows up differently. The sector needs operators, molders, CNC specialists, quality engineers, validation staff, regulatory people, and supplier quality teams in the same building. That is a harder staffing mix than a general job shop faces.

11. AdvaMed says Minnesota and Utah have the highest concentration of medical technology jobs relative to total employment, each at more than 3x the national average. Source: AdvaMed.
12. Delaware, Massachusetts, and Indiana follow, each at more than 2x the national average concentration of medtech jobs. Source: AdvaMed.
13. California has more than 70,000 medtech jobs, the largest named state total in AdvaMed’s highlights. Source: AdvaMed.
14. Florida has more than 14,000 medtech jobs. Source: AdvaMed.
15. An older AdvaMed economic update said medtech directly employed 397,000 people at an average annual salary of $88,096, which was 49% higher than the average across all industries and 18% higher than the manufacturing premium. Source: AdvaMed 2021 update.
16. The jump from 397,000 direct jobs in 2021 to 519,000 in the current AdvaMed fact base implies growth of roughly 122,000 direct jobs across that period. Source comparison: 2021 AdvaMed release and current AdvaMed fact page.

Market size, output, and trade statistics

Buyers searching for medical device manufacturers want to know whether the sector is still expanding and whether U.S. capacity matters globally. The answer to both is yes. The commercial story is not just hospitals buying devices. It is also diagnostics, wearables, minimally invasive tools, single-use consumables, and electronics-heavy systems that keep pulling more advanced manufacturing work into the category.

17. IBISWorld estimates the U.S. medical device manufacturing industry at $58.0 billion in 2025. Source: IBISWorld market size page.
18. Grand View Research estimates the broader U.S. medical device manufacturers market at $256.2 billion in 2024 and $270.1 billion in 2025. Source: Grand View Research.
19. The increase from $256.2 billion to $270.1 billion implies about 5.4% year over year growth in that market model. Source calculation from Grand View Research.
20. AdvaMed’s economic fact base puts annual U.S. medtech exports at more than $44 billion. Source: AdvaMed.
21. The same AdvaMed fact set reports over $113 billion in personal income tied to the industry’s direct and indirect employment footprint. Source: AdvaMed.
22. Every $4.00 in medtech revenues generates another $3.00 in total state revenues. Source: AdvaMed.
23. Every $15.00 in medtech payroll generates another $14.00 in total state payroll. Source: AdvaMed.
24. FRED tracks employment, hourly compensation, and industrial production for NAICS 3391, medical equipment and supplies manufacturing, which is a useful signal that this is big enough to be treated as its own industrial series. Sources: employment series, hourly compensation series, and industrial production series.
25. The Federal Reserve’s industrial production series for NAICS 3391 runs from January 1972 through January 2026, giving manufacturers and analysts more than 54 years of history to benchmark long-term output trends. Source: FRED.

FDA and regulatory statistics

This is where medical device manufacturing gets different from most industrial categories. A supplier is not just selling parts. It is selling traceability, validation discipline, process control, CAPA readiness, and clean documentation. If you market to medtech buyers, your proof points need to speak that language.

26. The FDA has established classifications for approximately 1,700 generic device types. Source: FDA device classification overview.
27. Those device types are grouped into 16 medical specialty panels. Source: FDA.
28. The FDA uses 3 regulatory classes for devices: Class I, Class II, and Class III. Source: FDA.
29. For many Class I and Class II devices that are not exempt, the route to market is a 510(k) submission. Source: FDA.
30. Class III devices generally require a premarket approval application, PMA. Source: FDA.
31. Device classification is based on intended use and indications for use, not just physical design. Source: FDA.
32. Risk level is a major factor in class assignment, with Class I as lowest risk and Class III as greatest risk. Source: FDA.
33. FDA’s FY2024 performance reporting, summarized by Emergo by UL, said CDRH authorized 120 novel devices in 2024, including 42 breakthrough-designated devices and 47 de novo authorizations. Source: Emergo summary of FDA CDRH annual report.
34. The MDUFA V performance framework sets a shared outcome goal for 510(k) total time to decision at 108 days if certain revenue and performance conditions are met. Source: FDA MDUFA performance goals document.
35. The same framework sets a shared outcome goal for PMA total time to decision at 270 days under the same conditional framework. Source: FDA MDUFA performance goals.

Innovation and technology adoption statistics

The link-worthy part of this sector is not only the market size. It is the way medical device manufacturing keeps pulling in new process technology. Miniaturization, AI-assisted diagnostics, imaging, wearable sensors, and robot-assisted procedures all force manufacturers to upgrade tooling, automation, validation, and electronics assembly capabilities.

36. AdvaMed says medical advancements, including medtech-enabled diagnoses and treatments, increased life expectancy by more than 5 years from 1980 to 2019. Source: AdvaMed Medtech Saves.
37. Medtech helped reduce the duration of hospital stays by 38% since 1980, according to AdvaMed’s public campaign. Source: AdvaMed.
38. A longer-run AdvaMed economic fact page says advanced medical technology reduced hospital days by 59% between 1980 and 2010. Source: AdvaMed.
39. Medtech reduced fatalities from heart disease and stroke by 49% since 1990. Source: AdvaMed.
40. Improved screenings and imaging helped reduce breast cancer deaths by 43% from their 1989 peak. Source: AdvaMed.
41. Improved screenings and imaging helped reduce prostate cancer deaths by 53% from their 1993 peak. Source: AdvaMed.
42. Overall cancer deaths have fallen 32% since 1990, with better medtech part of that story. Source: AdvaMed.
43. Medtech spending increased at an annual rate of 3.1% from 2009 to 2019, lower than the 4.3% rate for overall health spending. Source: AdvaMed.
44. Since the 1970s, average hospital stays have dropped from 11 days to 5 days. Source: AdvaMed.
45. The use of minimally invasive surgical procedures reduced workplace absenteeism by 53,000 person-years. Source: AdvaMed.
46. Across diabetes, colorectal cancer, musculoskeletal disease, and cardiovascular disease, key medical technologies expanded U.S. GDP by $106.2 billion and created a $23.6 billion net annual economic benefit. Source: AdvaMed.
47. Top annual U.S. procedures tied directly to medtech include 1.175 million C-sections, 1 million breast biopsies, 800,000 knee replacements, 500,000 open-heart surgeries, and 400,000 hysterectomies. Source: AdvaMed.
48. A 2025 paper indexed in PubMed Central found the FDA authorized 168 machine learning-enabled Class II devices in 2024, with 94.6% cleared via 510(k) and 5.4% via De Novo. Source: PMC study.

State and regional medtech cluster statistics

This is where the SEO angle gets interesting. Buyers often search for medical device manufacturers by state, region, or metro because qualification risk is lower when they can visit a plant or source inside an established cluster. If you sell into this market, regional proof matters.

You can read those numbers two ways. First, they tell you where the existing buyer density sits. Second, they tell you where suppliers need to look if they want shorter sales cycles. A sterilization vendor in Minnesota, a precision plastics molder in Utah, or an electronics assembler in Southern California is not trying to create demand from scratch. They are working inside an already dense buying network.

49. AdvaMed specifically calls out Silicon Valley and Los Angeles as California medtech concentration areas. Source: AdvaMed.
50. It calls out the Boston-Cambridge region as the center of Massachusetts medtech density. Source: AdvaMed.
51. Minnesota’s hub is centered in the Twin Cities area. Source: AdvaMed.
52. Florida’s medtech footprint is highlighted in Jacksonville, South Florida, and the I-4 Corridor. Source: AdvaMed.
53. Indiana is called out for specialization in cardiovascular, diagnostic, and surgical devices. Source: AdvaMed.
54. Maryland is noted as having more than 44,000 jobs in the life sciences sector, which helps explain its medtech supplier relevance even if not all of those jobs are device manufacturing. Source: AdvaMed.

2026 outlook and benchmark takeaways

The 2026 outlook is pretty straightforward. This sector still has the tailwinds. Aging populations, chronic disease management, wearables, outpatient procedures, AI-enabled diagnostics, and pressure to shorten hospital stays all keep demand moving. The harder question is who captures the work.

Expect more market growth in high-value categories tied to therapy delivery, glucose monitoring, imaging, and in vitro diagnostics. That will keep pushing the healthcare industry toward more automation, more software-enabled quality control, and more scrutiny around reimbursement, patient outcomes, and supplier documentation. For manufacturers, that means the medical device market is still attractive, but the standard for execution keeps rising.

Manufacturers that win in this category tend to have a few things in common. They document everything. They speak regulatory language without sounding like lawyers. They can show validation and quality systems in plain English. And they make it easy for a buyer to believe they will not create downstream risk.

55. The FDA classification universe of 1,700 device types across 16 panels means the market is broad, but it is not generic. Source: FDA.
56. The three-class risk structure means a supplier serving Class III work is operating in a much narrower, more defensible niche than a commodity shop selling simple Class I devices. Source: FDA.
57. More than 80% of firms having fewer than 50 employees means the supplier base is fragmented, which usually creates room for better-positioned, better-marketed specialists. Source: AdvaMed.
58. The compensation profile, $84,000 average total compensation, shows this is not a race-to-the-bottom labor market. Source: AdvaMed.
59. The export base, $44 billion+, shows U.S. medtech manufacturing still matters globally. Source: AdvaMed.
60. The rise of 168 ML-enabled Class II device authorizations in 2024 shows software and AI are moving from trend deck material into authorized products. Source: PMC.
61. The U.S. market estimate of $270.1 billion in 2025 from Grand View Research shows why contract manufacturers, electronics assemblers, sterilization companies, and plastics molders keep chasing medtech work even with the higher qualification bar. Source: Grand View Research.

Sources

1. AdvaMed. Job Creation, Medical Device Industry Facts.
2. AdvaMed. Medtech: Making Americans Healthy Again.
3. AdvaMed. New Data Finds Medical Technology Industry Continues to Create High-Paying Jobs at Small Businesses Throughout COVID-19 Pandemic.
4. FDA. Classify Your Medical Device.
5. FDA. MDUFA Performance Goals and Procedures, Fiscal Years 2023 through 2027.
6. Emergo by UL. US FDA CDRH 2024 Annual Report Summary.
7. PubMed Central. Machine Learning-Enabled Medical Devices Authorized by the U.S. FDA in 2024.
8. FRED. Employment for Manufacturing: Medical Equipment and Supplies Manufacturing (NAICS 3391).
9. FRED. Hourly Compensation for Manufacturing: Medical Equipment and Supplies Manufacturing (NAICS 3391).
10. FRED. Industrial Production: Manufacturing: Durable Goods: Medical Equipment and Supplies (NAICS 3391).
11. IBISWorld. Medical Device Manufacturing in the US Market Size Statistics.
12. Grand View Research. U.S. Medical Device Manufacturers Market Size Report.